PSA Prodrug-Based Multimodality Agents for Imaging Metastatic Prostate Cancer

doi 10.21236/ada525527
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Metastatic Prostate Cancer With Highest Reported PSA Level

Acta Medica Marisiensis
2016English

Prostate Cancer Screening With PSA: "Aequanimitas"

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2013English

Simulation Optimization of PSA-threshold Based Prostate Cancer Screening Policies

Health Care Management Science
MedicineHealth Professions
2012English

PSA Screening for Prostate Cancer: Why So Much Controversy?

Asian Journal of Andrology
MedicineUrology
2013English

Prostate-Specific Antigen (PSA) Assay for Early Detection of Prostate Cancer Recurrence

Science-Business eXchange
2009English

Prognostic Significance of Rising Prostate-Specific Antigen (PSA) Levels Following Radiation Therapy for Localized Prostate Cancer—Comparison Between PSA Bounce Versus PSA Recurrence

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Prostate-Specific Membrane Antigen Based Antibody-Drug Conjugates for Metastatic Castration-Resistance Prostate Cancer

Cureus
2020English

From Indecision to Precision: Advances in Imaging in Metastatic Prostate Cancer

World Journal of Urology
Urology
2019English

Training for Multimodality Imaging

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy